It is well documented that candidiasis triggers type 3 responses initiated by activated IL-17-secreting cells These responses have been linked to tumor-promoting infiltrates of inflammatory cells and pose an antagonistic action to interferon-gamma (IFN-γ), a recognized anti-cancer defense mechanism (64). This evidence concerns the gene IFNG and candidiasis.